Korean Circ J.  2022 Dec;52(12):876-877. 10.4070/kcj.2022.0288.

Cardiac Resynchronization Therapy in Pediatric Patients and Congenital Heart Disease: What Issues Remain to Solve?

• Huh J

• KMID: 2536789
• DOI: http://doi.org/10.4070/kcj.2022.0288

Reference

1. Shin HJ, Park YH, Cho BK. Recent surgical outcomes of congenital heart disease according to Korea Heart Foundation data. Korean Circ J. 2020; 50:677–690. PMID: 32212426.

2. Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015; 132:2118–2125. PMID: 26369353.

3. Ahn JE, Kim ST, Kwon HW, et al. Late outcomes of pediatric and congenital heart disease patients following cardiac resynchronization therapy. Korean Circ J. 2022; 52:865–875. PMID: 36478648.

4. Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009; 95:1165–1171. PMID: 19307198.

5. Kim M, Kim TH. Finding cardiac resynchronization therapy responders: postprocedural QRS-T morphologies matter. Korean Circ J. 2020; 50:1074–1076. PMID: 33258316.

6. Miyazaki A, Negishi J, Hayama Y, et al. Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based strategy for congenital heart disease. Heart Vessels. 2019; 34:1340–1350. PMID: 30863899.